73 related articles for article (PubMed ID: 1381866)
21. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
Ferrer Roca OF; Ramos A; Diaz Cardama A
Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of the functional status of estrogen receptor cascade in breast cancer.
Kolár Z; Ehrmann J; Dusková M
Neoplasma; 1998; 45(2):83-7. PubMed ID: 9687888
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical study on estrogen receptors in conventionally formalin-fixed, paraffin-embedded tissues of endometrial carcinoma].
Zhang ZG; Xu MH; Wang MQ
Zhonghua Fu Chan Ke Za Zhi; 1994 Nov; 29(11):667-9, 699-700. PubMed ID: 7712889
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.
Pertschuk LP; Masood S; Simone J; Feldman JG; Fruchter RG; Axiotis CA; Greene GL
Gynecol Oncol; 1996 Oct; 63(1):28-33. PubMed ID: 8898164
[TBL] [Abstract][Full Text] [Related]
26. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
27. Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor.
Coffer AI; Spiller GH; Lewis KM; King RJ
Cancer Res; 1985 Aug; 45(8):3694-8. PubMed ID: 4016747
[TBL] [Abstract][Full Text] [Related]
28. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI
Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
30. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
31. [Clinical studies on recurrent prostatic cancer].
Suzuki K; Nakamura T; Kato N; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1991 Jun; 37(6):595-600. PubMed ID: 1892007
[TBL] [Abstract][Full Text] [Related]
32. [Prostatic specific antigen in the serum in prostatic cancer].
Fuse H; Akakura K; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1987 Jul; 33(7):1049-53. PubMed ID: 2446484
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of prostatic cancer].
Kudo K; Nagata M; Hayashi N; Imamura H; Iwamoto K; Kimura M; Matsubara M; Mimura H; Matsuyama K; Suwa J
Hinyokika Kiyo; 1989 Aug; 35(8):1339-45. PubMed ID: 2816599
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
[TBL] [Abstract][Full Text] [Related]
35. [Present status and questions on early prostatic cancer (stage A, B)].
Oishi K; Arai Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
[TBL] [Abstract][Full Text] [Related]
36. Assessment of hormone receptor status in breast cancer.
Horii R; Akiyama F; Ito Y; Iwase T
Pathol Int; 2007 Dec; 57(12):784-90. PubMed ID: 17988279
[TBL] [Abstract][Full Text] [Related]
37. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
38. An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer.
Takeda H; Yamakawa M; Takahashi T; Imai Y; Ishikawa M
Cancer; 1992 Feb; 69(4):907-12. PubMed ID: 1735082
[TBL] [Abstract][Full Text] [Related]
39. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.
Ciocca DR; Luque EH
Breast Cancer Res Treat; 1991 Dec; 20(1):33-42. PubMed ID: 1667487
[TBL] [Abstract][Full Text] [Related]
40. Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.
Giri DD; Dangerfield VJ; Lonsdale R; Rogers K; Underwood JC
J Clin Pathol; 1987 Jul; 40(7):734-40. PubMed ID: 3305584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
